Progress in diagnosis and treatment of mucinous ovarian cancer
10.19401/j.cnki.1007-3639.2024.01.006
- VernacularTitle:卵巢黏液性癌的诊治进展
- Author:
Tong LI
1
;
Huijuan YANG
Author Information
1. 复旦大学附属肿瘤医院胸外科,复旦大学遗传工程国家重点实验室,复旦大学胸部肿瘤研究所,复旦大学上海医学院肿瘤学系,上海 200032
- Keywords:
Ovarian cancer;
Mucinous ovarian cancer;
Progress in diagnosis and treatment
- From:
China Oncology
2024;34(1):90-96
- CountryChina
- Language:Chinese
-
Abstract:
Mucinous ovarian cancer(MOC)is a rare pathological type different from epithelial ovarian cancer,and the clinical treatment should refer to serous ovarian cancer(SOC)guidelines.However,since the clinicopathological features of MOC are significantly different from SOC,careful differentiation is needed in diagnosis and treatment.Surgery combined with adjuvant chemotherapy is the standard treatment for MOC.However,due to the low prevalence rate,it is difficult to carry out clinical trials,hence lacking evidence-based medicine and consensus on the indications of intraoperative appendectomy and the choice of postoperative adjuvant chemotherapy.In addition,further translational preclinical studies of targeted therapy and immunotherapy are needed to facilitate the diagnosis and individualized treatment of MOC.
